UniProtKB/Swiss-Prot P26196 : Variant p.His372Arg
Probable ATP-dependent RNA helicase DDX6
Gene: DDX6
Feedback ?
Variant information
Variant position:
372
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LP/P [Disclaimer : Variants classification is intended for research purposes only, not for clinical and diagnostic use . The label disease variant is assigned according to literature reports on probable disease-association that can be based on theoretical reasons. This label must not be considered as a definitive proof for the pathogenic role of a variant. ]
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Histidine (H) to Arginine (R) at position 372 (H372R, p.His372Arg).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from medium size and polar (H) to large size and basic (R)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
In IDDILF.
Any additional useful information about the variant.
Sequence information
Variant position:
372
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
483
The length of the canonical sequence.
Location on the sequence:
KKISQLGYSCFYIHAKMRQE
H RNRVFHDFRNGLCRNLVCTD
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human KKISQLGYSCFYIHAKMRQEH RNRVFHDFRNGLCRNLVCTD
Mouse KKISQLGYSCFYIHAKMRQEH RNRVFHDFRNGLCRNLVCTD
Chicken KKISQLGYSCFYIHAKMRQEH RNRVFHDFRNGLCRNLVCTD
Xenopus laevis KKISQLGYSCFYIHAKMRQEH RNRVFHDFRNGLCRNLVCTD
Xenopus tropicalis KKISQLGYSCFYIHAKMRQEH RNRVFHDFRNGLCRNLVCTD
Drosophila KKITELGYCCYYIHAKMAQAH RNRVFHDFRQGLCRNLVCSD
Slime mold KKITELGYSCFFIHAKMVQAH RNRVFHDFRNGACRNLVSSD
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 483
Probable ATP-dependent RNA helicase DDX6
Domain
308 – 468
Helicase C-terminal
Region
307 – 483
RecA-like domain 2
Mutagenesis
353 – 353
K -> A. In LK-AA; abolishes interaction with PATL1 and reduces interaction with GIGYF1, GIGYF2, EDC3, EIF4ENIF1 and LSM14A; when associated with A-349. In 4xmut; abolishes interaction with EDC3; when associated with A-324; A-328 and A-349.
Mutagenesis
386 – 386
R -> E. Abolished ability to regulate RNA metabolism.
Helix
370 – 381
Literature citations
Rare de novo missense variants in RNA helicase DDX6 cause intellectual disability and dysmorphic features and lead to P-body defects and RNA dysregulation.
Balak C.; Benard M.; Schaefer E.; Iqbal S.; Ramsey K.; Ernoult-Lange M.; Mattioli F.; Llaci L.; Geoffroy V.; Courel M.; Naymik M.; Bachman K.K.; Pfundt R.; Rump P.; Ter Beest J.; Wentzensen I.M.; Monaghan K.G.; McWalter K.; Richholt R.; Le Bechec A.; Jepsen W.; De Both M.; Belnap N.; Boland A.; Piras I.S.; Deleuze J.F.; Szelinger S.; Dollfus H.; Chelly J.; Muller J.; Campbell A.; Lal D.; Rangasamy S.; Mandel J.L.; Narayanan V.; Huentelman M.; Weil D.; Piton A.;
Am. J. Hum. Genet. 105:509-525(2019)
Cited for: FUNCTION; SUBCELLULAR LOCATION; INTERACTION WITH LSM14A; LSM14B; EIF4ENIF1; PATL1; EDC3 AND EDC4; INVOLVEMENT IN IDDILF; VARIANTS IDDILF ARG-372; GLN-373; ARG-390; ILE-391 AND PRO-391; CHARACTERIZATION OF VARIANTS IDDILF GLN-373; ARG-390; ILE-391 AND PRO-391;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.